High-throughput crystallographic fragment screening of Zika virus NS3 Helicase.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
29 Apr 2024
29 Apr 2024
Historique:
medline:
15
5
2024
pubmed:
15
5
2024
entrez:
15
5
2024
Statut:
epublish
Résumé
The Zika virus (ZIKV), discovered in Africa in 1947, swiftly spread across continents, causing significant concern due to its recent association with microcephaly in newborns and Guillain-Barré syndrome in adults. Despite a decrease in prevalence, the potential for a resurgence remains, necessitating urgent therapeutic interventions. Like other flaviviruses, ZIKV presents promising drug targets within its replication machinery, notably the NS3 helicase (NS3
Identifiants
pubmed: 38746241
doi: 10.1101/2024.04.27.591279
pmc: PMC11092484
pii:
doi:
Types de publication
Preprint
Langues
eng